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ABSTRACT 
Objective: The main objective of this study was to optimize the noneffervescent floating mini tablets (NEFT) formula of ranitidine hydrochloride 
(ranitidine HCl) using the simplex lattice design (SLD) with parameters, granule flow rate, hardness, friability, floating lag time and ranitidine HCl 
dissolution test (%). 
Methods: The material was prepared using the SLD model was cassava starch fully pregelatinized (CSFP), hydroxypropyl methylcellulose K4M 
(HPMC K4M), and magnesium stearate. The formula obtained was tested for critical parameters, namely flow rate, hardness, friability, floating lag 
time and ranitidine HCl dissolution test (%). The dissolution test was carried out by using the USP type II method (paddle method). The beaker is 
immersed in the water bath of temperature 37 °C. It is filled with 900 ml of 0.1 N HCl, and the apparatus was set at 75 rpm. The samples were taken 
in the interval of 10 min and estimated content by a spectrophotometer at 312 nm. 
Results: The optimum formula based on superimposed graphs of various contour plots with SLD. From the experimental data for all test 
parameters, the experimental results are approaching with the results of the prediction. The condition for optimum functional components in NEFT 
was 80 mg for CSFP, HPMC K4M 30 mg, and 10 mg magnesium stearate to obtain a yield of 7.85 kg hardness, 0.34 % friability, 15.27 floating lag 
time and 91.31 % ranitidine HCl dissolved. 
Conclusion: It can be concluded that the optimum formula using the Design-Expert®
Keywords: Cassava starch fully pregelatinized, Noneffervescent, Floating mini tablets, Optimization, Simplex lattice design 
 program the SLD concept is obtained in the range of 70-80 mg 
CSFP, 30-40 mg HPMC K4M, 0-10 mg magnesium stearate. 




Amylum as an excipient in pharmaceutical formulations is very 
widely used because it can be mixed with almost all drugs and is 
inert without causing chemical reactions [1]. Amylum is often used 
as an excipient, such as binders. Binder functions to power the mass 
cohesion of powder at press time. Binding materials influence the 
dissolution rate of the drug [2]. The more strongly bound an active 
substance is with excipients and will not be able to dissolve in the 
body, and not achieve the expected bioavailability [3-5]. 
Amylum is a reserve polysaccharide that is abundant in plants. In 
general, starch consists of water-soluble components (amylose) as 
much as 20 % and water-insoluble parts (amylopectin) as much as 
80 % [6]. Amylose is a straight molecule, consisting of 250–300 D-
glucose units and is uniformly linked by α-1,4-glucoside bonds, 
which tends to cause the molecule to be shaped like a helix [7-9]. 
Amylopectin consists of 1,000 or more glucose units, most of which 
is also associated with α-1.4 bonds. However, there are also a 
number of α-1.6 bonds found at the branching points [10, 11]. This 
number of bonds are approximately 4 % of the total number of 
relationships or one for every 25 glucose units. Amylopectin in 
water can form colloidal solutions [12, 13]. When the colloidal 
solution is heated a sticky period occurs, this property is used as a 
binder. Amylose has the ability to expand when in contact with 
liquids, this property is used as a destroyer [14-16]. 
Modification of the physical properties of starch was carried out in a 
pregelatinized manner. The purpose of this modification is to 
improve the flow properties and its compatibility so that it can be 
used as a binder in printed tablets directly and can reduce glidan 
and antiadherent use [17]. The use of glidan and antiadherent can 
extend dissolution rates because it can form a film layer [18]. 
Modification of pregelatinized starch was carried out by giving the 
treatment in the form of adding the right amount of water and 
heating at the appropriate temperature. This method produces 
starch with larger particle size and higher particle density [19]. In 
pregelatinized starch due to the addition of proper water and 
heating, a gel formation process causes the starch granules to absorb 
water and expand to form a thick mass [20]. 
One of the local plants producing starch that can be modified in this 
way is cassava amylum. In addition to its relatively cheap price, 
cassava amylum is relatively easy to obtain, so it is potential to be 
used as a solid dosage excipient [21]. Amylopectin content is high, 
which is equal to 83 %, making cassava starch potential to be used 
as a binder in the manufacture of pharmaceutical preparations [22]. 
The aim of the study was to optimize the NEFT formula of ranitidine 
HCl using the CSFP base on SLD design.  
MATERIALS AND METHODS 
Materials 
The study used tubers of cassava (Manihot esculenta Crantz) as the 
basic ingredient to make starch. The cassava was obtained from 
Banyuning Village in Bali, Indonesia. The botanical identity of the 
plant and determination already done in the Eka Karya Bali plant 
conservation center, voucher specimen number B-451. The starch 
was prepared using fully pregelatinized methods [23], with the 
addition of distilled water and then heating above the starch 
gelatinating temperature, ranitidine HCl (Chemo Lugano), HPMC 
K4M® (Colorcon), magnesium stearate, all ingredients mentioned 
have pharmaceutical qualities. Sodium chloride, methanol (Merck p. 
a), distilled water, aquabides, acetonitrile (Merck p. a), and raw 
material ranitidine HCl (catalog number 66357-59-3 SIGMA). 
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Instrumentation and software 
Tablet machine (Korsh® USA single punch), JASCO FT-IR-4200 type 
A model, Electromagnetic Sieve Shaker EMS-8, Electrolab Tap 
density tester EDT-1020, Oakton pH 510 series, oven, Erweka Type 
TA/TR 120, Erweka Disintegrator tester ZT X20, Electrolab 
Dissolution tester (USP) TDL-08L, and UV-Vis spectrophotometry 
(Genesys). DoE was computed and analyzed applying Design-
Experts® software 7.1.5 (computer lab Gadjah Mada University). 
CSFP preparation 
The CSFP was made with a starch: distilled water ratio of 1:1 (w/v). The 
mixture was then stirred until a homogenous suspension was formed. 
The suspension was heated with water vapour at a temperature 80 °C in 
a drum, which was closed for 15 min, until gelatinization occurred. The 
pregelatinized starch was then dried in an oven at 50 °C or 48 h. Once 
dried, it was sieved using a 20-mesh sieve [24-26]. 
Preparation of granules  
The wet granulation method of massing and screening was used 150 
g batches of formulated mixtures of ranitidine HCl, CSFP, HPMC 
K4M, and magnesium stearate were mixed [27]. In small batches the 
ingredients may be mixed in stainless steel bowls or mortars. They 
were then moistened with polyvinylpyrrolidone K 30 (
Quantities (150 g) of granules from each batch were compressed into 
tablets with predetermined loads on single tablet press with a 8 mm 
die and flat faced punch assembly. A set of tablets was produced from 
each pressure. After ejection, the tablets were stored in airtight 
containers to allow for elastic recovery and hardening, prevent falsely 
low yield values before the tablets were subjected to analysis [31, 32]. 
PVP K-30) 
binder solution to yield 2 % w/w, PVP in the final dried granulation. 
The resulting wet masses were granulated by passing them 
manually through a 10 mesh sieve, dried oven at 50 °C for 7 h, and 
then re-sieved through a 20 mesh sieve. The dried granules were 
lubricated by using magnesium stearate [28-30].  
Preparation of NEFT  
Dissolution test  
The dissolution test was carried out by using the USP type II method 
(paddle method). The beaker is immersed in the water bath of 
temperature 37 °C. It is filled with 900 ml of HCl 0.1 N and the apparatus 
was set at 75 rpm. The samples were taken in an interval of 10 min and 
estimate the content by spectrophotometer at 312 nm. The same 
procedure was repeated at different time intervals and absorbance was 
noted and the percentage drug release was calculated [33, 34].  
Formula design according to SLD 
Based on the Design-Expert® version 7.1.5, for the optimization method 
with SLD, with 3 independent variables (mixture of 3 components) 14 
experiments were conducted on various mixed compositions for the 
three components, there are repetitions of several formulas according to 
those suggested by the Design-Expert® program [35, 36]. 
In this study, the variables to be optimized are CSFP (X1), HPMC K4M 
(X2) and magnesium Stearate (X3). The total mixture of X1+X2+X3 for 
each formula was 120 mg, with a total weight of 150 mg mini tablets 
containing 33,48 mg ranitidine HCl. Determination of the minimum 
and maximum limits for the three components optimized based on the 
results of the literature study and preliminary research [37, 38]. 
The SLD was used to optimize the NEFT formula for ranitidine HCl 
tablets with variations in the levels of CSFP 70-80 mg, and HPMC 
K4M 30-40 mg, magnesium stearate 0-10 mg. The optimum formula 
using the Design-Expert®
 
 program is based on parameters: granule 
flow rate, hardness, friability, floating lag time, and ranitidine HCl 
dissolution test (%) [39]. 
 
Fig. 1:Fourier transform infrared (FT-IR) spectroscopy analysis of ranitidine HCl 
 
 
Fig. 2:Overlay ranitidine HCl+CSFP+magnesium stearate+HPMC K4M, Where: A: ranitidine HCl, B: CSFP, C: magnesium stearate, D: HPMC K4M 
 
RESULTS AND DISCUSSION 
Interaction study of ranitidine HCl with excipients in formulas 
By comparing the spectrum of single ranitidine HCl, a mixture of 
ranitidine HCl and CSFP and a mixture of ranitidine HCl with 
components present in the tablet gastroretentive formula (fig. 1 and 
fig. 2), it can be concluded that there is no chemical interaction (no 
chemical incompatibility) between components in the formula. The 
IR spectra showed that there was no chemical interaction that 
caused the formation of a bond between ranitidine HCl and 
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excipients in the formula. The presence of a new peak and loss of the 
original peak, indicates an interaction. [40]. Ranitidin HCl is 
incompatible with lactose fillers, PVP (polivinil pirolidone) polymers 
and there is mild interaction with eudragit E100 [41]. 
Simplex lattice design 
The SLD was used to optimize the NEFT formula for ranitidine HCl 
tablets with variations in the levels of CSFP 70-80 mg, and HPMC 
K4M 30-40 mg, magnesium stearate 0-10 mg. The optimum formula 
using the Design-Expert®
Material flow properties can be illustrated with parameters of flow 
velocity and angle of repose. The pregelatinized fully produced 
starch can flow through the funnel with a flow rate for 100 g less 
than 10 s. At the parameters of flow velocity, CSFP has a flow rate of 
6.23 s, while for the parameters of the angle of repose, and has an 
angle of repose of 32.570. This indicates that the modified material 
of the starch produced better flow properties. 
 program (table 1.) 
Flow properties 
From the data of the flow velocity test from all runes with the 
ANOVA test, the p-value value obtained with a 95 % significance 
level obtained the value of 0.0004 (<0.05). The p-value value with 
the quadratic model is lower than 0.05, indicating that there are 
significant differences in flow velocity due to the use of the three 
optimized ingredients. The lack of fit analysis with the results of the 
p-value of 0.0806 (>0.05) with a confidence level of 95 %, shows 
that there is no significant difference between the experimental data 
and the predicted data from the suggested model (table 2) 
 
Table 1: Proportion of each component according to the SLD 
Trial code Material (mg)/mini tablet 
CSFP HPMC K4M Magnesium stearate 
1 76.67 36.67 6.67 
2 80 40 0 
3 78.33 33.33 8.33 
4 75 35 10 
5 80 35 5 
6 80 40 0 
7 80 30 10 
8 80 30 10 
9 70 40 10 
10 70 40 10 
11 75 40 5 
12 78 38.33 3.33 
13 75 35 10 
14 73.33 38.33 8.33 
*Formula using the Design-Expert®
 
 program the SLD concept 
Table 2: Analysis of variance (ANOVA) of the flow properties 
Source Sum of squares  df Mean square F Value p-value prob>F   
Model 45.08 5 9.02 17.16 0.0004 Significant 





AB 0.56 1 0.56 1.06 0.3341 
AC 0.55 1 0.56 1.05 0.3345 
BC 12.28 1 12.28 23.37 0.0013 
Residual 4.2 8 0.53     
Lack of fit 3.47 4 0.87 4.74 0.0806 Not significant 
Pure error 0.73 4 0.18       
 Cor total 49.29 13       
*
 
From the data of the flow velocity ready for the press, the equation 
according to the SLD is obtained as follows:  
Flow rate (g/s) =-0,045 (A)+2,36 (B)+2,71 (C)-0,024 (A) (B)+0,029 
(A) (C)–0,14 (B) (C) 
Where:  
A = starch component fraction CSFP 
B = fraction of HPMC K4M components 
C = fraction of the Magnesium stearate component 
The p-value value indicating that there are significant differences in flow velocity due to the use of the three optimized ingredients. The values are 
mean±standard deviation of n=5. 
From the equation, it can be seen that the starch matrix component is 
fully pregelatinized, HPMC K4M and magnesium stearate and 
component interactions, influence the flow velocity. Individually CSFP 
has a negative effect, which means it can reduce flow velocity. For 
HPMC K4M and magnesium stearate individually, it is positive, which 
means it can increase flow speed. While the optimized two-component 
interaction of CSFP with HPMC K4M and HPMC K4M with magnesium 
stearate has a negative effect which means it can reduce flow velocity, 
while the interaction between CSFP with magnesium stearate has a 
positive effect which means it can increase flow speed. 
Hardness test  
For each formulation, the hardness of the tablets was determined 
individually using a hardness tester. The batch of all batches was 
found 8.52+0.231 kg. 
From the hardness test data from all runes with the ANOVA test, the 
p-value value obtained with a 95 % significance level obtained a 
value of 0.002 (<0.05). The p-value value with the quadratic model is 
lower than 0.05, indicating that there are significant differences in 
flow velocity due to the use of the three optimized ingredients. 
The lack of fit analysis with the results of the p-value 0.0879 (>0.05) 
with a confidence level of 95 %, shows that there is no significant 
difference between the experimental data and the predicted data 
from the suggested model (table 3). 
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Table 3: Analysis of variance (ANOVA) of the hardness test 
 Source Sum of squares  df Mean square F value p-value prob>F   
Model 7.88 5 1.57 11.05 0.002 Significant 





AB 2.47 1 2.47 17.4 0.0031 
AC 1.01 1 1.01 7.11 0.0288 
BC 0.025 1 0.025 0.18 0.0058 
Residual 1.14 8 0.14     
Lack of fit 0.93 4 0.23 4.48 0.0879 Not significant 
Pure error 0.21 4 0.052       
 Cor total 0.99 13       
*
 
From the data on tablet hardness, the equation according to the SLD 




A = starch component fraction fully pregelatinized 
B = HPMC K4M component fraction 
C = fraction of the Magnesium stearate component 
From the equation, it can be seen that the starch matrix component is 
fully pregelatinized, HPMC K4M and magnesium stearate and 
component interactions, influence the hardness. Individually the starch 
is fully pregelatinized, HPMC K4M, and magnesium stearate has a 
negative effect, which means it can reduce violence. While the optimized 
two-component interaction, which is CSFP with HPMC K4M and CSFP 
with magnesium stearate, has a positive effect which means it can 
increase hardness, while the interaction between HPMC K4M and 
magnesium stearate has a negative effect which means it can reduce 
violence. In fig. (fig. 5B), for the red area to get the optimum formula. 
The p-value value indicating that there are significant differences in flow velocity due to the use of the three optimized ingredients. The values are 
mean±standard deviation of n=5. 
Tablet friability 
According to the USPNF23, 10 tablets were randomly selected 
and placed in the drum of a tablet friability test apparatus. The 
drum was adjusted to rotate 100 times in 4 min then the tablets 
were removed from the drum, dedusted, and accurately weighed. 
The percent weight loss was calculated. The friability test of 
tablets of entire batches. Depicted that the tablets of entire 
batches had passed the USP criteria of variability testing (0.5–1 
%, w/w). The results revealed that tablets possess good 
mechanical strength. 
From friability testing data from all runes with ANOVA test, p-
value obtained with a significance level of 95 % obtained a value 
of 0.0046 (<0.05). The p-value value with the quadratic model is 
lower than 0.05, indicating that there are significant differences 
in probability tests due to the use of the three optimized 
ingredients. 
The lack of fit analysis with the results of the p-value of 0.0786 
(>0.05) with a confidence level of 95 %, indicates that there is no 
significant difference between the experimental data and the 
predicted data from the suggested model (table 4). 
 
Table 4: Analysis of variance (ANOVA) of the friability test 
 Source Sum of squares  df Mean square F value p-value prob>F   
Model 5.261 5 1.05 8.52 0.0046 Significant 





AB 1.032 1 1.03 0.84 0.3874 
AC 4.5 1 4.5 36.51 0.0003 
BC 5.864 1 5.86 4.75 0.061 
Residual 9.88 8 1.23     
Lack of fit 8.18 4 2.04 4.81 0.0786 Not significant 
Pure error 1.7 4 4.25       
 Cor total 6.24 13       
*
 
From the data friability of the tablet, the equation according to the 
SLD is obtained as follows:  
Friability (%) = 7.87 (A)+1.16 (B)+0.05 (C)-1.05 (A) (B)-8.36 (A) 
(C)+3,014 (B) (C) 
Where:  
A = starch component fraction fully pregelatinized 
B = HPMC K4M component fraction 
C = fraction of the Magnesium stearate component 
The p-value value indicating that there are significant differences in probability tests due to the use of the three optimized ingredients. The values 
are mean±standard deviation of n=5. 
From the equation, it can be seen that the starch matrix component 
is fully pregelatinized, HPMC K4M and magnesium stearate and 
component interactions, have an effect on variability. Individually 
the starch is fully pregelatinized, HPMC K4M, and magnesium 
stearate has a positive effect, which means it can improve friability. 
While the optimized two-component interaction, which is CSFP with 
HPMC K4M and CSFP with magnesium stearate, has a negative effect 
which means it can reduce friability, while the interaction between 
HPMC K4M and magnesium stearate has a positive effect which 
means it can improve friability. 
Floating lag time 
Comparison of excipients 
The floating tablets were prepared by wet granulation. Each tablet 
contained ranitidine HCl (33.4 mg), matrix-forming polymers 30 mg 
(different grades of HPMC) combination with CSFP (80 mg) and 
magnesium stearate (10 mg). Different grades of HPMC are HPMC 
K100LV combination with CSFP, HPMC K4M combination with CSFP, 
HPMC K15M combination with CSFP. The results showed that the 
HPMC K4M combination with CSFP could provide immediate 
floatation upon contact with the dissolution medium and were able 
to continuously float over 24 h (table 5). 
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Table 5: Floating lag time 
Comparison of excipient Floating lag time (min)+SD 
HPMC K4M combination with CSFP 15.304+0.089 
HPMC K100LV combination with CSFP 16.402+0.085 
HPMC K15M combination with CSFP 23.874+1.706 
*
 
Floating lag time describes the time needed by the tablet when it 
starts to be inserted into the test medium until the tablet floats. 
Floating time parameters are very important for gastroretentive 
tablet preparations with floating systems. The results of the 
literature study do not yet have information about what is the best 
floating lag time for gastroretentive tablets. The results of the 
study show that gastroretentive tablets have a floating time of 13-
32 min. 
HPMC K4M combination with CSFP could provide immediate floatation upon contact with the dissolution medium.  The values are mean±standard 
deviation of n=5. 
The results of testing for flotation for up to 24 h of observations, the 
tablet is still floating. The tablet floats because the starch is fully 
pregelatinized by the medium and causes the tablet to expand, and 
the gel is formed by the presence of the HPMC K4M matrix in tablet 
formulas so as to maintain the integrity of the tablet. 
From the floating lag time test data from all runs with the ANOVA test, 
the p-value value obtained with a 95 % significance level obtained a 
value of 0.0318 (<0.05). The p-value value with the quadratic model is 
lower than 0.05, indicating that there are significant differences in flow 
velocity due to the use of the three optimized ingredients. 
The lack of fit analysis with the results of p-value 0.0746 (>0.05) 
with a confidence level of 95 %, shows that there is no significant 
difference between the experimental data and the predictive data 
from the suggested model (table 6). 
 
Table 6: Analysis of variance (ANOVA) of the floating lag time test 
Source Sum of squares  df Mean square F value p-value prob>F   
Model 469.12 5 93.62 4.4 0.0318 Significant 
Linier mixture 215.4 2 107.7 5.05 0.0381  
AB 241.31 1 241.31 11.32 0.0099 
AC 11.34 1 11.34 0.53 0.4866 
BC 1.73 1 1.73 0.081 0.7828 
Residual 170.52 8 21.31   
Lack of fit 142 4 35.5 4.98 0.0746 Not significant 
Pure error 28.52 4 7.13    
Cor total 639.64 13    
*
 
From the floating lag time tablet data, the equation according to the 
SLD is as follows:  
Floating lag time (min) =-7.27 (A)-25.47 (B)+4.62 (C)+0.51 
(A)(B)+0.13 (A)(C)-0,052 (B)(C) 
Where:  
A = starch component fraction fully pregelatinized 
B = HPMC K4M component fraction 
The p-value value with the indicating that there are significant differences in flow velocity due to the use of the three optimized ingredients. The 
values are mean±standard deviation of n=5. 
C = fraction of the Magnesium stearate component 
From the equation, it can be seen that the starch matrix 
component is fully pregelatinized, HPMC K4M and magnesium 
stearate and component interactions, have an effect on friability. 
Individualism CSFP has a negative effect, while HPMC K4M, and 
magnesium stearate have a positive effect, which means it can 
increase the floating lag time. While the optimized two-component 
interaction, which is CSFP with HPMC K4M and CSFP with 
magnesium stearate, has a positive effect which means it can 
increase the floating lag time, while the interaction between HPMC 
K4M and magnesium stearate has a negative effect, which can 
reduce the floating lag time. 
 
Dissolution test  
Validation method 
Table 7: Analysis LOD and LOQ 
Concentration Absorbancy (y) y' y'-y (y'-y)2 
10 0.461000 0.466400 0.005400 0.000029 
12 0.558000 0.547400 -0.010600 0.000112 
13 0.592000 0.587900 -0.004100 0.000017 
14 0.615000 0.628400 0.013400 0.000180 
15 0.671000 0.668900 -0.002100 0.000004 
17 0.752000 0.749900 -0.002100 0.000004 
18 0.789000 0.790400 0.001400 0.000002 
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Fig. 3:The curve of ranitidine HCl in 0.1 N HCl dissolution medium 
 
The maximum wavelength of ranitidine HCl was obtained in 0.1 N 
HCl medium at 312 nm. The linear regression equation obtained y = 
0.0405X+0.0614 (Y = absorbancy and X = ranitidine HCl content) 
with a correlation coefficient of 0.9955 
 
 
Fig. 4:Profil average dissolved of ranitidine HCl in the HCl 0.1 N, the values are mean±standard deviation of n=5 
 
Table 8: Analysis of variance (ANOVA) of the dissolved of ranitidine HCl in the HCl 0.1 N 
 Source Sum of squares  df Mean square F value p-value prob>F   
Model 390.23 5 78.05 5.63 0.0162 significant 





AB 162.29 1 162.29 11.7 0.0091 
AC 172.59 1 172.59 12.44 0.0078 
BC 23.37 1 23.37 1.68 0.2304 
Residual 110.97 8 13.87     
Lack of fit 22.7 4 5.68 0.26 0.8915 not significant 
Pure error 88.27 4 22.07       
 Cor total 501.2 13       
*
 
The release profile of ranitidine HCl from a tablet has a similar profile, which is slow release. The values are mean±standard deviation of n=5. 
Abbreviations: F: formulations. 
Fig. 4 shows that the release profile of ranitidine HCl from a tablet 
has a similar profile, which is a slow release. In the initial phase until 
the 60th min, the release is still quite large and is followed by slower 
release until it reaches steady state. 
From the data of ranitidine HCl dissolved (%), the equation obtained:  
Ranitidine HCl dissolved (%) = 7.39(A)+20.88(B)+34.84(C)-0.42(A) 
(B)-0.52(A)(C)-0.19(B)(C) 
Where:  
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A = starch component fraction fully pregelatinized 
B = HPMC K4M component fraction 
C = fraction of the Magnesium stearate component 
ANOVA results of the quadratic model, the calculated probability 
value (p-value) = 0.0162. The calculated p-value is less than 0.05 
indicating the model/equation obtained is significant (model fit) at 
the 95% confidence level. The equation model obtained can be used 
to navigate the design space. 
From the above equation shows that each component 
individually has a positive effect which means it can increase 
dissolitidine HCl dissolved (%). Two-component interaction 
produces a coefficient that is negative, which means it can 
reduce the speed of release. 
 
 
Fig. 5: Interaction factors A, B, and C on flow properties (A), interaction factors A, B, and C on hardness (B), Interaction factors A, B, and C 
on friability (C), Interaction factors A, B, and C on floating lag time (D), Interaction factors A, B, and C on dissolution (E) 
 
Optimization 
The selection of the optimum condition (fig. 6) is formula 1, 
focused on the highest desirability value (table 8). The 
optimization process for NEFT has been evaluated by 
desirability value, the condition for optimum functional 
components in NEFT was 80 mg for CSFP, HPMC K4M 30 mg, and 
10 mg magnesium stearate to obtain a yield of 7.85 kg hardness 
(fig. 5B), 0.34 % friability (fig. 5C), 15.27 floating lag time (fig. 5D) 
and 91.31 % ranitidine HCl dissolved (fig. 5E). 
 
 
Fig. 6: Superimposed graphs of various contour plots 
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Table 8: Solutions for 3 combinations of category factor levels 
 CSFP(mg) HPMC K4M (mg) Magnesium stearate (mg) Floating lag time (min) Dissolution (%) Desirability  
1 80 30 10 15.27 91.31 0.764 Selected 
2 70 40 10 19.73 89.77 0.587  
3 70 40 10 18.87 91.55 0.577  
4 79 39 2 30.88 82.66 0.216  
5 79 40 1 31.80 82.19 0.202  
*
 
The selection of the optimum condition is formula 1, focused on the highest desirability value. 
Table 9: Verification optimum formula 
Response Sample p-value 
Experiment Prediction 
Flow rate (g/s)±SD 18.02+0.18 17.84+0.15 0.51 
Hardness (kg)±SD 8.11+0.27 7.85+0.35 0.44 
Friability (%)±SD 0.32+0.02 0.34+0.05 0.38 
Floating lag time (min)±SD 15.12+0.09 15.27+0.06 0.63 
Dissolution (%)±SD 91.28+0.45 91.31+0.65 0.82 
*
 
The values are mean±standard deviation of n=5. 
The experimental response data for the selected optimum formula 
was analyzed using the independent sample test for the T-test in the 
open state software to find out whether there was a difference in the 
response value of the SLD prediction. At the 95% confidence level, 
the p-value for all responses is greater than 0.05. This means that all 
response data have no significant difference in the response value of 
the SLD prediction. It can be concluded that between the verification 
data and predicted data statistically have no difference or have the 
same value. 
CONCLUSION 
The optimization process for NEFT has been evaluated by 
desirability value, the condition for optimum functional components 
in NEFT was 80 mg for CSFP, HPMC K4M 30 mg, and 10 mg 
magnesium stearate to obtain a yield of 7.85 kg hardness, 0.34 % 
friability, 15.27 floating lag time and 91.31 % ranitidine HCl 
dissolved. 
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